Abiopharma

News list

Sarchi Christopher 🔴 sold 6.5K shares of Replimune Group, Inc. (REPL) at $8.01 Transaction Date: Apr 02, 2026 | Filing ID: 039967

Full text

News bot April 6, 2026, 8:31 p.m.
🔍 Sarchi Christopher (Executive)

Company: Replimune Group, Inc. (REPL)

Report Date: 2026-04-02
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 6,500
Detailed Transactions and Holdings:
- Sold 6,500 shares of Common Stock at $8.01 per share (Direct)
  Date: 2026-04-02 | Code: S | equity_swap_involved: 0 | shares_owned_after: 151,588.00 | transaction_form_type: 4 | Footnotes: F1, F2, F3
Footnotes:
- F1: The sales reported on this Form 4 were made by the reporting person pursuant to a trading plan adopted on December 15, 2025, that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended.
- F2: The price reported reflects a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.00 to $8.06. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- F3: Following the sales reported on this Form 4, the reporting person continues to beneficially own 151,588 shares of the Issuer's common stock, including restricted stock units. The reporting person also holds options to acquire an aggregate of 250,425 shares of the Issuer's common stock, 142,555 of which are exercisable as of the date hereof.